Biovance Capital Partners SCR

Peter Villax is CEO of Mediceus and a partner at Biovance Capital, with additional roles as director at Hoviana Ventures Ltd and president of the Associação das Empresas Familiares. He coordinates Cliniceum, a 14-member consortium seeking Horizon Europe funding to develop and scale a privacy-preserving digital health platform designed for GDPR compliance and alignment with the European Health Data Space, involving partners across eight countries.

Team member at Biovance who highlights Fund I as a milestone for Portugal's biomedical ecosystem and the firm's support of biotech companies across Europe.

Team member with over twenty years fostering industry-academia collaborations at Portugal's largest health research institute, focused on advancing European biomedical research globally.

Ana Pinheiro is an External Sustainability Consultant at Biovance Capital with over 10 years of operations management experience in venture capital funds across Portugal and the UK. She provides consulting services in sustainability and SFDR compliance. Her educational background includes a Master's degree in Culture Studies from Catholic University of Portugal, a Bachelor's degree in English from the University of Lisbon, and post-graduate qualifications in Applied Management from Nova SBE and Dermocosmetics from the University of Barcelona.

Hannah Franklin is an Associate at Biovance Capital, Portugal's dedicated biotech venture fund with €60M+ under management that invests in early-stage therapeutic companies across Europe. She holds a background in neuroscience research, including academic work in neurodegeneration and stem cell models, and prior experience in early-stage venture at SCI Ventures. Franklin also serves as a Board Observer at Laigo Bio and engages in science communication and mentorship for early-career researchers transitioning into venture capital and industry roles.

Kristina Beeler is an Advisory Board Member at Biovance Capital with over 13 years of experience in life sciences commercial and business development. Her work focuses on commercializing research technologies for biopharma, spanning product strategy and execution across drug discovery and translational research, in collaboration with biotech and pharmaceutical organizations.